跳至主要内容
临床试验/NCT01324336
NCT01324336已完成不适用

Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets

Children's Mercy Hospital Kansas City1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Pharmacokinetics of 6-MP

研究概览

简要总结

The purpose of this study is to compare the pharmacokinetics of a routinely used compounded liquid formulation of 6-mercaptopurine (6-MP) with commercially available tablets in patients who are receiving treatment with 6-MP as part of their clinical treatment for acute lymphoblastic leukemia (ALL).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
4 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients ages 4-17 years of age who are receiving maintenance chemotherapy treatment for ALL with 6-MP will be included.

排除标准

  • Inability to have blood drawn for the screening lab tests
  • Received methotrexate or folate supplement within the last 24 hours
  • Pregnant or lactating females
  • Inability to swallow a pill
  • Hemoglobin less or equal to 8 gm/dl
  • Presence of significant co-morbid illness that makes child ineligible as deemed by the investigator
  • Weight < or = 16 kg

研究组 & 干预措施

4-17 years, receiving 6-MP

干预措施: 6-Mercaptopurine (Drug)

结局指标

主要结局

Pharmacokinetics of 6-MP

时间窗: 8 hours post administration

To compare the pharmacokinetics of a routinely used compounded liquid formulation of 6-mercaptopurine (6-MP) with commercially available tablets in patients who are receiving treatment with 6-MP as part of their clinical treatment for acute lymphoblastic leukemia (ALL).

次要结局

未报告次要终点

研究者

发起方
Children's Mercy Hospital Kansas City
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Comparative Pharmacokinetics of a Compounded... | 临床试验